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It is a constant challenge to the physician performing
percutaneous transluminal coronary angioplasty (PTCA) to
judge when a PTCA result is adequate to relieve symptoms
and provide a low likelihood of restenosis and when the
result is inadequate and further dilations or devices are
necessary. The ability of stents to limit dissections and
restenosis is acting as the true catalyst for a continuous
increase in elective stenting. However, several reports have
highlighted the discrepancies between patients undergoing
stent insertion in the “real world” and the select group of
patients studied in a randomized trial (1). Furthermore,
stent implantation has engendered a new and clinically
frustrating entity—in-stent restenosis. Routine stent im-
plantation is also more expensive than balloon angioplasty.
Powerful evidence for the improved efficacy of PTCA is
apparent on examination of the clinical outcomes of angio-
plasty in the balloon arms of some recently completed trials
(2). A strategy of more “aggressive” balloon dilation, with
the limited use of “provisional” stenting for complicated or
suboptimal balloon results, may be highly effective (3). At
present, the critical question is, how do we prospectively
identify which patients treated with successful angioplasty
will benefit from adjunctive stent placement? In an attempt
to answer this question, in this issue of JACC, van Liebergen
et al. (4) give us important information. They demonstrated
in a small and select sample that after angiography-guided
PTCA, adjunctive intravascular ultrasound (IVUS)-guided
balloon angioplasty induced an additional increase in hy-
peremic blood velocity related to a reduction of residual
lumen obstruction. Subsequent elective stent implantation
resulted in a further increase of coronary lumen dimensions,
whereas the hyperemic blood flow velocity variables re-
mained unchanged, indicating the absence of a functional
residual lumen obstruction after IVUS-guided balloon an-
gioplasty. The authors (4) suggest the presence of a plateau
phase of the optimal hemodynamic response in relation to
the residual lumen obstruction, which can be achieved using
IVUS-guided balloon angioplasty. With IVUS-guided bal-
loon angioplasty, the balloon-to-artery ratio increased from
1.07 6 0.14 to 1.35 6 0.21, a value close to that reported in
the Core LaboratOry UlTrasound analysis (CLOUT) study
(5). A 50% increase in early gain produced a 44% decrease
in percent diameter stenosis. Of note, this “aggressive”
balloon angioplasty strategy did not increase the incidence
of major dissections. This study gives us the chance to make
some consideration on how to address the problem of
“provisional” stenting.
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IVUS-guided balloon angioplasty. To achieve a larger
postprocedural minimal lumen diameter (MLD), proper
sizing of the balloon to the arterial segment to be dilated by
the selective use of IVUS may be a strategy to enhance
balloon angioplasty. Intravascular ultrasound guidance facil-
itates decision-making in terms of balloon sizing, especially
in angiographically small vessels that might be large vessels
with diffuse atherosclerosis (6). We recently found that the
ratio between the angiographic and IVUS reference diam-
eter is significantly lower in small vessels than in large
vessels (0.7 vs. 0.8, p , 0.001), supporting the concept that
angiographically small vessels might in fact be large vessels
with diffuse atherosclerosis (7). As a consequence, balloons
chosen for PTCA based on IVUS measurements appear to
be oversized angiographically. This discrepancy between
IVUS and angiographic vessel size is explained on the basis
of a large plaque burden. The application of balloons sized
larger than the true vessel size (external elastic membrane)
would be expected to result in major arterial disruption and
a higher risk of dissections. Even if this complication was
not frequently seen in the IVUS-guided PTCA studies
(5,6), the occurrence of dissections should not necessarily be
seen as a significant complication owing to the easy avail-
ability of stents.
Physiologic guidance of balloon angioplasty. Physiologic
guidance of an intervention with intracoronary Doppler
(8–10) and pressure measurement (11) is a new concept to
optimize the results. The coronary Doppler guide wire was
the first practical method of physiologic assessment of
coronary stenosis severity applicable in the catheterization
laboratory, correlating to the results of noninvasive nuclear
stress tests. The last 20 years have seen rapid changes in
intracoronary Doppler technology, with progressive minia-
turization of the transducers and refinement of signal
analysis. The large piezoelectric crystals mounted at the tip
of standard 8F Sones or Judkins catheters have been
replaced by circular transducers attached to 3F intracoronary
catheters and, more recently, by a miniaturized crystal at the
tip of 0.018-in. and 0.014-in. guide wires. The real-time
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spectral analyzer using on-line fast Fourier transformation
provides a gray-scale spectral display. The system software
automatically tracks the instantaneous peak velocity and
calculates on-line the average peak velocity over two con-
secutive beats. The Doppler wire can be detached from the
rotary connection so that PTCA balloons or other interven-
tional devices can be advanced over it. The wire can then be
reconnected to monitor the flow velocity changes during
and immediately after PTCA and to repeat the flow reserve
assessment after treatment.
Measurements of coronary flow reserve (CFR) (i.e., the
ratio of coronary flow under maximal coronary dilation to
coronary flow under rest conditions) using the Doppler
guide wire represent a potential end point on which to base
the decision of whether to provisionally stent a lesion after
balloon angioplasty has been completed.
In the study of van Liebergen et al. (4), CFR increased
after standard balloon angioplasty from 1.5 6 0.6 to 2.6 6
0.7 toward the CFR measured in the normal adjacent
coronary artery (3.2 6 0.7, relative CFR 0.83 6 0.22).
Adjunctive IVUS-guided balloon angioplasty resulted in a
further increase in hyperemic blood flow velocity, whereas
adjunctive stent implantation did not yield a further gain in
the hyperemic blood flow velocity, indicating the absence of
a functional residual lumen obstruction after IVUS-guided
balloon angioplasty. The lumen area after IVUS-guided
balloon angioplasty was 10.24 6 2.22 mm2. From these
data, we can extrapolate that 5.80 mm2 (the lowest lumen
area according to the standard deviation) was not flow
limiting. Abizaid et al. (12) recently demonstrated that an
IVUS minimal lumen area $4.0 mm2 had a diagnostic
accuracy of 89% in identifying a CFR $2.0. Thus, a further
increase in the lumen area by stent implantation may not
necessarily produce an increase in CFR. However, it should
be noted that in the study of van Liebergen et al. (4), the
CFR after IVUS-guided balloon angioplasty was 2.69 6
2.22; this means that the lowest CFR was 1.1. This stresses
the Achilles’ heel of Doppler velocity measurements—that
is, the large overlap between normal and abnormal values
inherent to every method using absolute CFR as an end
point. Reported threshold values of CFR for clinical
decision-making range from as low as 1.8 to 3 (8,13). The
wide scatter of threshold values created a relative uncertainty
among groups currently using the technology and has
deterred those who were about to implement physiologic
measurements. To improve the diagnostic accuracy of the
test and to identify false positive flow reserve measurements
(normal scintigraphy with CFR ,2), measurement of flow
reserve in a second artery without significant stenosis has
been advocated. The relative CFR is the ratio between CFR
in the artery under evaluation and CFR in the normal artery
(13). The disadvantage of the concept lies in the necessity to
perform another measurement in a reference vessel.
Significant changes in baseline flow can be assumed to
explain why the CFR may remain depressed after angio-
plasty or even after stent implantation. An increase in
baseline flow may occur because of removal of the epicardial
stenosis, repetitive administration of vasodilating drugs,
endogenous vasodilatory mediators in response to the
angioplasty procedure, suppression of vasoconstrictive sub-
stance, endothelium-dependent vasodilation and hemo-
dilution (14). Finally, impairment of autoregulatory mech-
anisms may cause an increased rest flow. Prolonged
vasodilation of the coronary vessels resulting from low flow
perfusion may impair the autoregulatory adaptive process.
Abrupt restoration of normal perfusion may then fail to
induce appropriate regulatory adaptation, resulting in hy-
peremic rest flow. In contrast, the maximal increase in
hyperemic blood flow might be impaired in response to
repetitive episodes of ischemia during balloon angioplasty
(14). In addition, the maximal vessel stretch produced by
stenting could impair the effective dilation of the microvas-
cular bed, explaining the lack of further improvement in
CFR despite an increase in lumen gain (15). A different
explanation for the reduction of flow reserve after PTCA or
stenting could be the damage produced by particulate
embolization occurring during the procedure. Of note is
that CFR determined directly after coronary angioplasty
and CFR determined after six months in the presence of an
unchanged angioplasty result may dissociate, depending on
the improvement or the worsening of the mocrovascular bed
(14).
Recently, the value of intracoronary Doppler measure-
ments for assessment of coronary stenosis severity has been
challenged by the concept of the myocardial fraction flow
reserve (FFR), which is based on intracoronary pressure
measurement (11). Fraction flow reserve is defined as the
ratio of the hyperemic flow in the stenotic coronary artery to
the hyperemic flow in that same artery (or territory) in the
hypothetical case in which the epicardial vessel were com-
pletely normal. In contrast to the CFR, the concept of FFR
has presented a threshold value and does not seem to be
affected by the status or the responsiveness of the distal
vascular bed. An FFR value ,0.75 indicates a hemodynam-
ically significant stenosis with high accuracy and reproduc-
ible induction of myocardial ischemia on the basis of stress
tests and thallium scintigraphy.
Long-term outcome and restenosis rate. Restenosis is a
complex process involving vessel recoil, remodeling and
intimal smooth muscle cell hyperplasia. The beneficial
effects of stent implantation on restenosis have been attrib-
uted to: 1) the larger early lumen dimension achieved; and
2) the positive effect on chronic recoil and remodeling. Early
recoil accounts for a 50% loss in early lumen gain during
standard balloon angioplasty. At present there are only
preliminary and indirect data on the relation between
optimal (both anatomic and functional) balloon angioplasty
and chronic elastic recoil and vessel remodeling (9–11).
Preliminary results of the Doppler Endpoints Stent Inter-
national Investigation (DESTINI) trial (9) indicate that
when optimal angiographic and physiologic end points (e.g.,
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final residual diameter stenosis ,35%, final CFR .2.0) are
met after PTCA, the early and late clinical outcomes are
equivalent to the outcomes observed after elective stent
implantation. It is interesting to note that in the PTCA
group only 43% of patients could achieve the predetermined
end points. This limitation may be related to the angio-
graphic and non–IVUS-guided balloon sizing used in the
DESTINI trial.
Clinical implications. A possible clinical implication of
this emerging field of IVUS-guided PTCA and
physiologic-guided interventions is that after optimal “guid-
ed” PTCA, further stenting may not be necessary. An
alternative conclusion could be that because of the fact that
elective stenting gives the same results of optimal “guided”
PTCA, this last modality may not be necessary, provided
elective stenting is applied routinely.
A few other important aspects need to be considered: 1)
if it is realistic to assume that in lesions located on small
vessels and bifurcational lesions coronary stenting may
perform inferiorly to PTCA, the need to avoid elective
stenting may be appropriate and alternative solutions such
as IVUS-guided angioplasty will be welcome; 2) in long
lesions the use of long stents may perform inferiorly as
compared with spot stenting and adjunctive PTCA (16,17);
IVUS guidance will therefore become an important tool for
decision-making; and 3) a strategy of elective stenting needs
to be evaluated, taking into account the changing cost of
stenting, IVUS catheters and procedural time.
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